Improving Function, Quality of Life, Glycemia in Diabetics With Dementia
Status:
Withdrawn
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine if the study medication Methylphenidate
(Ritalin) will improve subject's blood-sugar control by improving their motivation more than
placebo. The secondary objectives of the study are to determine if daily functioning and
quality of life improves with methylphenidate treatment.